Fever and serum ferritin > 684 ng/ml and any 2 of the following:
Fever serum ferritin 1502 ng/ml
Platelet count ≤181 × 109/L
Platelet count 116 × 109/L
Aspartate aminotransferase >48 U/L
Aspartate aminotransferase 925 U/L
Triglycerides > 156 mg/dl
Triglycerides 628 mg/dl
Fibrinogen ≤360 mg/dl
Fibrinogen 166 mg/dl
Table 1: Input Parameters
All rivaroxaban event rates from the ROCKET-AF trial reduced by 35%
ASA = acetyl salicylic acid; CDR = clinical dementia rating scale; mRS = modified Rankin scale adapted by the Oxfordshire Community Stroke Project to assess patient functional deficits at hospital discharge.
FIGURE 1
Figure 1: Heliotrope rash
FIGURE 2
Figure 2: Gottron’s papules
FIGURE 3
Figure 3: Skin ulcerations
FIGURE 4
Figure 4: Diffusely hyperintensed signal of the thighs and subcutabeous edema
FIGURE 5
Figure 5: Enhancement of subcutaneous tissue after contrast administration
Tables at a glance
Figures at a glance